Standout Papers

Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pool... 2018 2026 2020 2023 323
  1. Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012 (2018)
    Ranee Mehra, Tanguy Y. Seiwert et al. British Journal of Cancer

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 63 standout
Sub-graph 1 of 21

Citing Papers

Targeting KRAS: from metabolic regulation to cancer treatment
2025 Standout
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach
2025 Standout
4 intermediate papers

Works of Deepti Aurora-Garg being referenced

Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC
2023
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
2018 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Deepti Aurora-Garg 1050 684 281 28 1.3k
Chan-Young Ock 1004 501 253 42 1.4k
Paola Casieri 616 491 210 43 1.4k
Sergi Benavente 914 538 187 33 1.4k
Jill Walker 1257 931 584 57 1.7k
Ricardo E. Vilain 1156 447 200 40 1.6k
William A. Kokal 656 261 237 25 1.4k
Hui‐Lan Rao 645 216 142 44 1.1k
Ping Yang 1104 380 236 26 1.6k
Ritesh Rathore 821 240 108 44 1.0k
Karl Heath 1248 444 184 14 1.6k

All Works

Loading papers...

Rankless by CCL
2026